Blood tests are the first step and often catch leukemia before symptoms do

A doctor usually suspects leukemia from a complete blood count (CBC), a standard blood test that measures red cells, white cells, and platelets. In leukemia, the white cell count is often very high or very low, and the cells themselves look abnormal under a microscope. The CBC is fast—results come back in hours—and it is what prompts a doctor to order the tests that actually confirm leukemia.

The CBC alone cannot diagnose leukemia. It can show that something is wrong with blood cell production, but leukemia looks similar to other serious blood disorders on a CBC alone. That is why a positive CBC leads to a bone marrow test, which is the test that actually confirms the diagnosis.

Key Takeaways

  • A complete blood count (CBC) is usually the first test and shows abnormal white cell counts or appearance, but cannot diagnose leukemia on its own.
  • A bone marrow biopsy is the test that confirms leukemia by showing whether blast cells (immature cancer cells) are present in the marrow.
  • Flow cytometry identifies the specific type of leukemia by analyzing the surface markers on the abnormal cells.
  • Cytogenetic testing and molecular tests look for specific genetic changes that affect treatment options and prognosis.
  • Imaging tests like chest X-rays or CT scans check whether leukemia has spread to organs outside the blood and bone marrow.

Bone marrow biopsy: the test that confirms the diagnosis

A bone marrow biopsy is a procedure in which a doctor uses a needle to remove a small sample of bone marrow, usually from the back of the hip bone. The sample is sent to a lab where a pathologist looks at it under a microscope. If leukemia is present, the marrow will contain a high percentage of blast cells—immature white blood cells that have become cancerous and are crowding out normal cells.

The procedure takes 10 to 15 minutes. A local anesthetic numbs the skin and the outer layer of bone, so you feel pressure but not sharp pain. Some people describe it as uncomfortable rather than painful. Afterward, the hip may be sore for a few days, similar to a bruise. Serious complications like infection or bleeding are rare.

The pathologist also counts what percentage of cells in the marrow are blasts. In healthy bone marrow, blasts make up less than 5 percent of cells. A diagnosis of acute leukemia typically requires 20 percent or more blasts. This percentage matters because it affects which type of leukemia you have and how quickly it needs treatment.

Flow cytometry identifies which type of leukemia you have

Flow cytometry is a lab test that uses fluorescent dyes and a laser to analyze the surface markers on individual cells. Each type of leukemia has a different pattern of markers, so flow cytometry can distinguish between acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). The test also shows whether the leukemia came from B cells or T cells, which affects treatment decisions.

Flow cytometry is done on a blood sample or bone marrow sample and takes one to two days. It is standard for anyone with a new leukemia diagnosis because the type of leukemia determines which drugs will work and what the likely course of the disease will be.

Cytogenetic and molecular tests reveal genetic changes that guide treatment

Leukemia cells often have specific genetic changes—extra chromosomes, missing pieces, or mutations in individual genes. These changes do not cause leukemia to be inherited; they happen only in the cancer cells themselves. But they matter enormously for treatment because some genetic changes make cells respond to certain drugs and not others.

A cytogenetic test looks at the chromosomes themselves under a microscope to spot large changes like the Philadelphia chromosome (found in most CML cases) or trisomy 21 (extra chromosome 21, found in some ALL cases). A molecular test looks for smaller mutations in specific genes. Common ones tested in AML include FLT3, NPM1, and CEBPA. In ALL, doctors often test for BCR-ABL fusion genes.

These tests take one to two weeks because the lab has to grow cells or run DNA analysis. But the results directly shape which drugs a doctor will recommend, so they are done before treatment starts. Some genetic changes predict a better or worse prognosis, which helps doctors and patients understand what to expect.

Imaging tests check whether leukemia has spread beyond the blood and marrow

Once leukemia is confirmed, a doctor may order imaging to see whether the cancer has spread to organs outside the blood and bone marrow. A chest X-ray is common and quick. A CT scan of the chest or abdomen gives more detail if the X-ray shows something abnormal or if the doctor suspects the spleen or liver is enlarged.

Leukemia cells can collect in the spleen, liver, lymph nodes, or central nervous system (brain and spinal cord). A lumbar puncture (spinal tap) may be done to check whether leukemia cells are in the fluid around the brain and spinal cord, especially in acute leukemias. This is a needle procedure similar to a bone marrow biopsy but done in the lower back, and it takes about 15 minutes.

Other blood tests measure organ function and guide treatment decisions

Before treatment starts, doctors order blood tests to measure kidney function, liver function, and electrolytes. Leukemia itself and the drugs used to treat it can damage these organs, so a baseline measurement lets doctors know what is normal for you and helps them spot problems early.

A test called lactate dehydrogenase (LDH) is often high in leukemia and is checked at diagnosis and during treatment. High LDH can mean there is a lot of cancer cell death happening, which is important information during the first weeks of treatment. Blood tests for uric acid are also common because leukemia cells break down rapidly and release uric acid, which can damage the kidneys.

The timeline from first test to diagnosis

If a doctor suspects leukemia based on symptoms or an abnormal CBC, the bone marrow biopsy is usually done within days. The pathologist can give a preliminary diagnosis within 24 hours based on what the marrow looks like under the microscope. Flow cytometry results come back in one to two days. Cytogenetic and molecular tests take longer—usually one to two weeks—but treatment often starts before those results are back if the diagnosis is clear and the leukemia is acute.

Chronic leukemias move more slowly, so doctors usually wait for all test results before starting treatment. The exact timeline depends on how sick you are, which type of leukemia is suspected, and how busy the lab is. Your doctor should tell you what to expect and when to expect results.

Frequently Asked Questions

Does a bone marrow biopsy hurt?

You feel pressure and sometimes a brief sharp sensation when the needle enters the bone, but local anesthetic prevents severe pain. Most people describe it as uncomfortable rather than painful. The procedure lasts 10 to 15 minutes, and soreness afterward is usually mild and goes away in a few days.

Can leukemia be seen on a regular blood test?

A complete blood count can show that something is wrong—abnormal white cell counts or blast cells visible under a microscope—but it cannot confirm leukemia on its own. A bone marrow biopsy is needed to confirm the diagnosis because it shows the percentage of blast cells in the marrow and allows the pathologist to rule out other conditions.

What if the first bone marrow biopsy is inconclusive?

If the sample is too small or the results are unclear, a second biopsy may be needed. This happens occasionally but is not common. Your doctor will tell you if this is necessary and when it will be scheduled.

How long does it take to get a leukemia diagnosis?

A preliminary diagnosis based on bone marrow appearance can come back in 24 hours. Flow cytometry results typically arrive in one to two days. Genetic tests take one to two weeks. If leukemia is acute and the diagnosis is clear from early tests, treatment often starts before all genetic results are back.

Are there any risks to the tests used to diagnose leukemia?

Blood tests carry minimal risk—just the small discomfort of a needle stick. Bone marrow biopsy and lumbar puncture are slightly more invasive but serious complications like infection or bleeding are rare. Your doctor will discuss any specific risks based on your health and blood counts.